April 6, 2016 / 10:22 AM / in a year

BRIEF-M Pharmaceutical agrees to acquire assets from Chelatexx

April 6 (Reuters) - M Pharmaceutical Inc

* Signs definitive agreement to acquire reformulated orlistat for weight loss from Chelatexx LLC

* Says addition of C-103 provides a novel weight loss pharmaceutical product to M Pharma pipeline

* Entered into a definitive agreement to acquire assets from Chelatexx LLC related to a reformulated version of orlistat

* Company also announced it was undertaking a non-brokered private placement of up to $700,000 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below